nedocromil has been researched along with Left Ventricular Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Janicki, JS; Jubair, S; Li, J | 1 |
1 other study(ies) available for nedocromil and Left Ventricular Dysfunction
Article | Year |
---|---|
Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.
Topics: Animals; Cardiomyopathy, Hypertrophic; Cell Degranulation; Cell Size; Chymases; Collagen; Estradiol; Estrogen Replacement Therapy; Female; Hypertrophy, Left Ventricular; Mast Cells; Myocardium; Myocytes, Cardiac; Nedocromil; Oligopeptides; Organ Size; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling | 2015 |